Browse resources

Disease: Meningococcus

Total results with these characteristics: 192

Page 3 of 8  
‹ prev.
1
2
3
4
5
6
next ›

Evaluation of Serogroup A Meningococcal Vaccines in Africa: A Demonstration Project

This article, published in The Journal of Health, Population, and Nutrition, summarizes the general steps required for meningococcal vaccine development, reviews the use of immunogenicity criteria as a licensing strategy for new meningococcal …

Author: Soriano-GabarrĂ³ M, Rosenstein N, LaForce FM

Published: 2004

Evaluation of the Meningitis Epidemics Risk Model in Africa

This study, published in Epidemiology and Infection, evaluated an ecological model based on absolute humidity and land cover type to predict the location of meningitis epidemics in the Sahelian region known as the African Meningitis Belt. The …

Author: Savory EC, Cuevas LE, Yassin MA, et al.

Published: 2006

Expanding Prevention of Invasive Meningococcal Disease

This article, published in Expert Review of Vaccines, discusses morbidity and mortality due to meningococcal serogroups A, C, Y, and W-135 and the ability of monovalent meningococcal serogroup C conjugate (MCC) vaccines to reduce the burden of …

Author: Pelton SI, Gilmet GP

Published: 2009

Fragile Lives - Immunization at Risk

Hailed as "the greatest public health success story of all time," today childhood immunization faces obstacles never seen before. While immunization still saves three million young lives each year, millions more could be saved if there were enough …

Author: PATH, Barraclough Productions

Published: 2004

From Genomics to Surveillance, Prevention and Control: New Challenges for the African Meningitis Belt

This article, published in the Bulletin de la Société de Pathologie Exotique, summarizes an international conference held in Niamey, Niger, that brought together more than 100 delegates to assess the current meningitis situation in Africa, …

Author: Alonso JM, Bertherat E, Perea W, et al.

Published: 2006

Global Alert and Response Disease Outbreak News: Meningococcal Disease

This web page provides regular updates on meningococcal disease outbreaks around the world as reported to the World Health Organization. It also serves as an archive, housing links to outbreak news alerts dating back to 1999.

Author: World Health Organization

Global and Regional Risk of Disabling Sequelae From Bacterial Meningitis: A Systematic Review and Meta-analysis

This article, published in The Lancet Infectious Diseases, provides an overview of a systematic review and meta-analysis of published papers from 1998 to 2008 to estimate the risks of major and minor sequelae caused by bacterial meningitis,  …

Author: Edmond K, Clark A, Korczak VS, et al.

Published: 2010

Global Epidemiology of Invasive Meningococcal Disease

Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. The worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and …

Author: Jafri RZ, Ali A, Messonnier NE, et al.

Published: 2013

Global Epidemiology of Meningococcal Disease

This article, published in the journal Vaccine, reviews meningococcal disease epidemiology and its variability across geographic area and time. The review summarizes the current status of meningococcal disease epidemiology by region, but notes that …

Author: Harrison LH, Trotter CL, Ramsay ME

Published: 2009

Global Epidemiology of Meningococcal Disease and Vaccine Efficacy

This article, published in the Pediatric Infectious Disease Journal, reviews outbreaks of meningococcal disease across the globe and the serotypes associated with these outbreaks. The author also discusses the different vaccines …

Author: Pollard AJ

Published: 2004

The Global Meningococcal Initiative: Recommendations for Reducing the Global Burden of Meningococcal Disease

The Global Meningococcal Initiative (GMI) is composed of an international group of scientists, clinicians, and public health officials that aim to promote the global prevention of invasive meningococcal disease through education and research. In …

Author: Harrison LH, Pelton SI, Wilder-Smith A, et al.

Published: 2011

Haemophilus influenzae type b (Hib)

This supplement to the Journal of Pediatrics features 13 original research articles on Hib. Several of the articles present new data on the impact of Hib vaccines in developing countries, including Bangladesh, The Gambia, Mongolia, and Mozambique. …

Author: Hajjeh R, Mulholland K, Santosham M, eds.

Published: 2013

Hope for Less Than 50 Cents a Dose: A Revolutionary Model for Developing Low-Cost Vaccines

This fact sheet describes the model employed by the Meningitis Vaccine Project to develop a safe, affordable, and long-lasting vaccine to combat Group A meningococcal epidemics in Africa, as well as the contributions of the key partners who made the …

Author: PATH

Published: 2011

Human Immunity to the Meningococcus: Development of Natural Immunity

This article, published in the Journal of Experimental Medicine, discusses a study in the United States that suggests that natural immunity to meningococcal disease is initiated, reinforced, and broadened by intermittent carriage of different …

Author: Goldschneider I, Gotschlich EC, Artenstein MS

Published: 1969

Human Immunity to the Meningococcus: Immunogenicity of Group A and Group C Meningococcal Polysaccharides in Human Volunteers

This article, published in the Journal of Experimental Medicine, provides a reinvestigation of the immunogenicity in human beings of the meningococcal group A and C antigens based on previous studies of the molecular weights of these polysaccharides …

Author: Gotschlich EC, Goldschneider I, Artenstein MS

Published: 1969

Human Immunity to the Meningococcus: Preparation and Immunochemical Properties of the Group A, Group B, and Group C Meningococcal Polysaccharides

This article, published in the Journal of Experimental Medicine, describes a new method for the isolation of the meningococcal group-specific polysaccharides that make it possible to produce highly purified group A and group C polysaccharides.

Author: Gotschlich EC, Liu TY, Artenstein MS

Published: 1969

Human Immunity to the Meningococcus: The Effect of Immunization With Meningococcal Group C Polysaccharide on the Carrier State

This article, published in the Journal of Experimental Medicine, discusses a small-scale field trial that was carried out in United States military recruits to test the effect of immunization with meningococcal C polysaccharide upon the …

Author: Gotschlich EC, Goldschneider I, Artenstein MS

Published: 1969

Human Immunity to the Meningococcus: The Role of Humoral Antibodies

This article, published in the Journal of Experimental Medicine, reviews an earlier study of the age-specific incidence of meningococcal meningitis in the United States that found that the proportion of individuals with serum bactericidal …

Author: Goldschneider I, Gotschlich EC, Artenstein MS

Published: 1969

A Hypothetical Explanatory Model for Meningococcal Meningitis in the African Meningitis Belt

Currently, no explanation exists for the epidemic pattern of meningitis in the African meningitis belt, in spite of recent progress in disease surveillance. Such a model would be conducive to mathematically mapping vaccine strategies or predicting …

Author: Mueller JE, Gessner BD

Published: 2010

Immune Response to Revaccination With Meningococcal A and C Polysaccharides in Gambian Children Following Repeated Immunization During Early Childhood

This article, published in the journal Vaccine, discusses a study of 42 Gambian children revaccinated at age five with meningococcal A/C polysaccharide vaccine (MPS) after receiving two doses of MPS in infancy and either MPS, meningococcal A/C …

Author: MacLennan J, Obaro S, Deeks J, et al.

Published: 1999

Immunization

This site offers information on vaccine and immunization programs at the American Academy of Pediatrics and includes video and text resources for parents. Resources include frequently asked questions for families, immunization information for …

Author: American Academy of Pediatrics

Immunization of Newborns with Bacterial Conjugate Vaccines

This article, published in Vaccine, discusses the use of bacterial conjugate vaccines in human newborns. Vaccines against Streptococcus pneumoniae, Haemophilus influenzae type B, and Neisseria meningiditis are covered. ABSTRACT ONLY: (Learn how …

Author: van den Biggelaar AH, Pomat WS

Published: 2013

Immunize Canada

This partnership of nongovernmental, professional, health, consumer, government, and private-sector organizations aims to promote the understanding and use of vaccines recommended by Canada's National Advisory Committee on Immunization. Its goal is …

Author: Immunize Canada

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

This article, published in The New England Journal of Medicine, discusses the methods and results of two studies conducted in Africa to evaluate a new meningococcal A conjugate vaccine. The conclusion of the studies is that the new vaccine has a …

Author: Sow SO, Okoko BJ, Diallo A, et al.

Published: 2011

Immunogenicity and Safety of a New Meningococcal A Conjugate Vaccine in Indian Children Aged 2-10 Years: A Phase II/III Double-Blind Randomized Controlled Trial

This article, published in Vaccine, describes a study that compared the immunogenicity and safety of a single dose of a new meningococcal A conjugate vaccine (PsA-TT, MenAfriVac™, Serum Institute of India Ltd.) against the meningococcal group …

Author: Hirve S, Bavdekar A, Pandit A, et al.

Published: 2012

Page 3 of 8  
‹ prev.
1
2
3
4
5
6
next ›